Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter?

Su, 2016, Epidemiology , genetic recombination , and pathogenesis of coronaviruses, Trends Microbiol., 24, 490, 10.1016/j.tim.2016.03.003

Chan-Yeung, 2003, SARS: epidemiology, Respirology, 8, S9, 10.1046/j.1440-1843.2003.00518.x

Zaki, 2012, Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia, N. Engl. J. Med., 367, 1814, 10.1056/NEJMoa1211721

Zhu, 2020, A novel coronavirus from patients with pneumonia in China, 2019, N. Engl. J. Med., 382, 727, 10.1056/NEJMoa2001017

Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet (London, England), 395, 507, 10.1016/S0140-6736(20)30211-7

Ji, 2020, Cross-species transmission of the newly identified coronavirus 2019-nCoV, J. Med. Virol., 92, 433, 10.1002/jmv.25682

Giannattasio, 2018, Coinfections with influenza virus and atypical bacteria: implications for severe outcomes?, Clin. Res. J, 12, 366, 10.1111/crj.12510

Li, 2005, Structure of SARS coronavirus spike receptor-binding domain complexed with receptor, Science, 309, 1864, 10.1126/science.1116480

Li, 2005, Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2, EMBO J., 24, 1634, 10.1038/sj.emboj.7600640

Walls, 2020, Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein, Cell, 10.1016/j.cell.2020.11.032

Glycoprotein, 2020, Structure , function , and antigenicity of the SARS- structure , function , and antigenicity of the SARS-CoV-2 spike glycoprotein, Cell, 1

Chiu, 2004, ACE2 gene polymorphisms do not affect outcome of severe acute respiratory syndrome, Clin. Chem., 50, 1683, 10.1373/clinchem.2004.035436

Imai, 2005, Angiotensin-converting enzyme 2 protects from severe acute lung failure, Nature, 436, 112, 10.1038/nature03712

Kuba, 2006, Angiotensin-converting enzyme 2 in lung diseases, Curr. Opin. Pharmacol., 6, 271, 10.1016/j.coph.2006.03.001

Kuba, 2005, A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury, Nat. Med., 11, 875, 10.1038/nm1267

Marshall, 2004, Angiotensin II and the fibroproliferative response to acute lung injury, Am. J. Physiol. Lung Cell Mol. Physiol., 286, L156, 10.1152/ajplung.00313.2002

Fyhrquist, 2008, Renin-angiotensin system revisited, J. Intern. Med., 264, 224, 10.1111/j.1365-2796.2008.01981.x

Gurwitz, 2020, Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics, Drug Dev. Res., 10.1002/ddr.21656

Stopsack, 2020, TMPRSS2 and COVID-19: serendipity or opportunity for intervention?, Canc. Discov., 10.1158/2159-8290.CD-20-0451

Matsuyama, 2010, Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2, J. Virol., 84, 12658, 10.1128/JVI.01542-10

Böttcher, 2006, Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium, J. Virol., 80, 9896 LP, 10.1128/JVI.01118-06

NCT04352400 C go I. Efficacy of Nafamostat in Covid-19 Patients (RACONA Study) (RACONA) (n.d).

Gaddam, 2014, ACE and ACE2 in inflammation: a tale of two enzymes, Inflamm. Allergy - Drug Targets, 13, 224, 10.2174/1871528113666140713164506

Hemnes, 2018, A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension, Eur. Respir. J., 51, 10.1183/13993003.02638-2017

Huentelman, 2005, Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats, Exp. Physiol., 90, 783, 10.1113/expphysiol.2005.031096

Jia, 2016, Pulmonary angiotensin-converting enzyme 2 (ACE2) and inflammatory lung disease, Shock, 46, 239, 10.1097/SHK.0000000000000633

Xue, 2014, Angiotensin-converting enzyme-2 overexpression attenuates inflammation in rat model of chronic obstructive pulmonary disease, Inhal. Toxicol., 26, 14, 10.3109/08958378.2013.850563

Dhawale, 2016, Activation of angiotensin-converting enzyme 2 (ACE2) attenuates allergic airway inflammation in rat asthma model, Toxicol. Appl. Pharmacol., 306, 17, 10.1016/j.taap.2016.06.026

Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N. Engl. J. Med., 10.1056/NEJMoa2002032

Zhang, 2020, Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China, Allergy, 10.1111/all.14238

Bianco, 2000, Expression of intercellular adhesion molecule-1 (ICAM-1) in nasal epithelial cells of atopic subjects: a mechanism for increased rhinovirus infection?, Clin. Exp. Immunol., 121, 339, 10.1046/j.1365-2249.2000.01301.x

Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5

Keidar, 2005, Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients, Circ. Res., 97, 946, 10.1161/01.RES.0000187500.24964.7A

Zhong, 2011, Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression, Regul. Pept., 166, 90, 10.1016/j.regpep.2010.09.005

Ferrario, 2005, Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2, Circulation, 111, 2605, 10.1161/CIRCULATIONAHA.104.510461

Ishiyama, 2004, Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors, Hypertension (Dallas), 43, 970, 10.1161/01.HYP.0000124667.34652.1a

Furuhashi, 2015, Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker, Am. J. Hypertens., 28, 15, 10.1093/ajh/hpu086

Yuan, 2015, Activation of renin-angiotensin-aldosterone system (RAAS) in the lung of smoking-induced pulmonary arterial hypertension (PAH) rats, J. Renin-Angiotensin-Aldosterone Syst. JRAAS, 16, 249, 10.1177/1470320315576256

Yang, 2014, Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury, Sci. Rep., 4, 7027, 10.1038/srep07027

Fang, 2020, Correspondence hypertension and increased risk for, Lancet Respir, 8, e21, 10.1016/S2213-2600(20)30116-8

European Society of Cardiology (ESC), 2020

American Heart Association (AHA), 2020

International Society of Hypertension, 2020

Trifirò, 2020, Should patients receiving ACE inhibitors or angiotensin receptor blockers be switched to other antihypertensive drugs to prevent or improve prognosis of novel coronavirus disease 2019 (COVID-19)?, Drug Saf., 10.1007/s40264-020-00935-2

European Society of Hypertension, 2020

Phadke, 2020, Use of angiotensin receptor blockers such as Telmisartan, Losartsan in nCoV Wuhan Corona Virus infections – novel mode of treatment, BMJ, 368, m406

Qiao, 2015, Ibuprofen attenuates cardiac fibrosis in streptozotocin-induced diabetic rats, Cardiology, 131, 97, 10.1159/000375362

Ali, 2018, Role of Wnt4/beta-catenin, Ang II/TGFbeta, ACE2, NF-kappaB, and IL-18 in attenuating renal ischemia/reperfusion-induced injury in rats treated with Vit D and pioglitazone, Eur. J. Pharmacol., 831, 68, 10.1016/j.ejphar.2018.04.032

Zhang, 2013, Pioglitazone upregulates hepatic angiotensin converting enzyme 2 expression in rats with steatohepatitis, Ann. Hepatol., 12, 892, 10.1016/S1665-2681(19)31294-3